Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.47 |
| ▸ | ECE1 | P42892 | 1/20 | 0.47 |
| ▸ | HRAS | P01112 | 3/20 | 0.47 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NMBR | P28336 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2276192 | 0.79 | QPCT (0.56) | — | |
| SCHEMBL11464237 | 0.78 | MME (0.55) | MMEECE1HRASFNTAFNTB | |
| SCHEMBL2177294 | 0.78 | FAAH (0.50) | — | |
| SCHEMBL28774675 | 0.77 | MME (0.61) | MMEECE1HRASFNTAFNTB | |
| SCHEMBL2199277 | 0.76 | FAAH (0.47) | MEN1KMT2A | |
| SCHEMBL14152015 | 0.76 | CYP3A4 (0.56) | MEN1KMT2A | |
| SCHEMBL2178184 | 0.76 | CYP3A4 (0.56) | MEN1KMT2A | |
| SCHEMBL2195381 | 0.76 | CYP3A4 (0.56) | MEN1KMT2A | |
| SCHEMBL28366545 | 0.76 | MME (0.61) | MMEECE1HRASFNTAFNTB | |
| SCHEMBL9230979 | 0.76 | MME (0.69) | MMEECE1HRASFNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8623900-B2 | Amino alcohol derivatives and their therapeutic activities | FLAMMA S.P.A. (IT) | 2014-01-07 | — | — | US | claimed |
| EP-2519507-B1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | FLAMMA SPA (IT) | 2013-10-16 | — | — | EP | claimed |
| US-20120316212-A1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | UNIVERSITA DEGLI STUDI DI MILANO (IT) | 2012-12-13 | — | — | US | claimed |
| EP-2519507-A1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | Flamma S.P.A. (IT) | 2012-11-07 | — | — | EP | claimed |
| WO-2011080139-A1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | FLAMMA S.P.A. (IT) | 2011-07-07 | — | — | WO | claimed |
| US-8623900-B2 | Amino alcohol derivatives and their therapeutic activities | FLAMMA S.P.A. (IT) | 2014-01-07 | — | — | US | disclosed |
| EP-2519507-B1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | FLAMMA SPA (IT) | 2013-10-16 | — | — | EP | disclosed |
| US-20120316212-A1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | UNIVERSITA DEGLI STUDI DI MILANO (IT) | 2012-12-13 | — | — | US | disclosed |
| EP-2519507-A1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | Flamma S.P.A. (IT) | 2012-11-07 | — | — | EP | disclosed |
| WO-2011080139-A1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | FLAMMA S.P.A. (IT) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316212-A1 | AMINO ALCOHOL DERIVATIVES AND THEIR THERAPEUTIC ACTIVITIES | ADH1A, ADH5, ADH1C | MME 2923/4885ECE1 1806/4885HRAS 3692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.